The group demonstrated that dexamethasone treatment reduced the expression of Nrf2, a key regulator of antioxidant responses, which was accompanied by a significant decrease in GSH in Panc1 cancer stem-like cells (CSLC) and PSN-1 CSLC [104]. The gene discussed is NFE2L2; the disease is cancer.